Research Peptide Comparison
CJC-1295 without DAC 5mg and PT-141 10mg are both Research Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
CJC-1295 without DAC, also referenced in the literature as Modified GRF 1-29, is a 30-amino-acid growth hormone-releasing hormone (GHRH) analog stabilised against enzymatic degradation but without the albumin-binding DAC moiety. Its short half-life produces a pulsatile GH-release profile that more closely approximates endogenous somatotropic signalling, making it a frequent reference compound in GHRH receptor and pituitary-response studies.
Compared to PT-141 10mg, CJC-1295 without DAC 5mg is priced at £27.99 with 99%+ verified purity. Its CAS registry number is 863288-34-0. It has a molecular weight of 3367.97 g/mol.
CJC-1295 without DAC 5mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £11.00 higher than PT-141 10mg.
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin-receptor agonist with primary activity at the MC3R and MC4R subtypes, exerting its effects through central nervous system signalling rather than peripheral vascular pathways. This mechanism has placed it at the centre of research into central arousal circuits, sexual health pharmacology and melanocortin-system pharmacology more broadly.
Compared to CJC-1295 without DAC 5mg, PT-141 10mg is priced at £16.99 with 99%+ verified purity. Its CAS registry number is 189691-06-3. It has a molecular weight of 1025.18 g/mol.
PT-141 10mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. At £11.00 less than CJC-1295 without DAC 5mg, it is the more affordable option in this comparison.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
